Elevation of Carbohydrate Antigen 19.9 in Benign Hepatobiliary Conditions and Its Correlation with Serum Bilirubin Concentration

Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice

DV Mann, Richard Edwards, Skinner Ho et al. · European Journal of Surgical Oncology · 2000 · 287 citations

Clinical Interpretation, Obstructive Jaundice, Medicine +8

A New Strategy for The Application of Ca19-9 in The Differentiation of Pancreaticobiliary Cancer: Analysis Using A Receiver Operating Characteristic Curve

Hong-Ja Kim, Myung‐Hwan Kim, Seung‐Jae Myung et al. · The American Journal of Gastroenterology · 1999 · 194 citations

Decrease of CA 19–9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer

U. Halm, Thomas L. Schumann, Ingolf Schiefke et al. · British Journal of Cancer · 2000 · 192 citations · Full text

Molecular genetic analysis of the human Lewis histo-blood group system.

Shoko Nishihara, Hisashi Narimatsu, Hiroko Iwasaki et al. · Journal of Biological Chemistry · 1994 · 191 citations · Full text

Histocompatibility, Cytogenetics, Genetics +22

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

Andrew H. Ko, Justin H. Hwang, Alan P. Venook et al. · British Journal of Cancer · 2005 · 162 citations · Full text